Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms J Abdi, G Chen, H Chang Oncotarget 4 (12), 2186, 2013 | 291 | 2013 |
miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma Y Yang, F Li, MN Saha, J Abdi, L Qiu, H Chang Clinical cancer research 21 (10), 2399-2411, 2015 | 124 | 2015 |
Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells J Abdi, J Garssen, J Faber, FA Redegeld The Journal of nutritional biochemistry 25 (12), 1254-1262, 2014 | 86 | 2014 |
Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS N Rastgoo, M Pourabdollah, J Abdi, D Reece, H Chang Leukemia 32 (11), 2471-2482, 2018 | 64 | 2018 |
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma N Rastgoo, J Abdi, J Hou, H Chang Journal of hematology & oncology 10, 1-10, 2017 | 62 | 2017 |
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis J Abdi, N Rastgoo, L Li, W Chen, H Chang Journal of hematology & oncology 10, 1-11, 2017 | 53 | 2017 |
Characterization of the Toll-like receptor expression profile in human multiple myeloma cells J Abdi, T Mutis, J Garssen, F Redegeld PloS one 8 (4), e60671, 2013 | 45 | 2013 |
Role of micro-RNAs in drug resistance of multiple myeloma J Abdi, H Jian, H Chang Oncotarget 7 (37), 60723, 2016 | 42 | 2016 |
Concise review: TLR pathway-miRNA interplay in mesenchymal stromal cells: regulatory roles and therapeutic directions J Abdi, I Rashedi, A Keating Stem cells 36 (11), 1655-1662, 2018 | 40 | 2018 |
MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc MN Saha, J Abdi, Y Yang, H Chang Oncotarget 7 (6), 7149, 2016 | 35 | 2016 |
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment J Abdi, L Qiu, H Chang Biomarker research 2, 1-6, 2014 | 34 | 2014 |
PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53 M Sobhani, J Abdi, SN Manujendra, C Chen, H Chang Cancer biology & therapy 16 (5), 799-806, 2015 | 29 | 2015 |
Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells J Abdi, N Rastgoo, Y Chen, GA Chen, H Chang BMC cancer 19, 1-12, 2019 | 25 | 2019 |
The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma J Abdi, F Engels, J Garssen, F Redegeld Critical reviews in oncology/hematology 80 (2), 225-240, 2011 | 25 | 2011 |
Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis J Abdi, T Mutis, J Garssen, FA Redegeld PloS one 9 (5), e96608, 2014 | 21 | 2014 |
Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model AA Kiani, J Abdi, R Halabian, MH Roudkenar, N Amirizadeh, ... Hematology 19 (2), 85-98, 2014 | 21 | 2014 |
Toll-like receptors in human multiple myeloma: new insight into inflammation-related pathogenesis J Abdi, J Garssen, F Redegeld Current Molecular Medicine 14 (4), 423-431, 2014 | 13 | 2014 |
Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells J Abdi, T Mutis, J Garssen, F Redegeld Blood cancer journal 3 (5), e119-e119, 2013 | 12 | 2013 |
Prevalence of alloimmunization against RBC antigens in thalassemia major patients of Lorestan province in 1383 A Kiani, J Abdi, Y Shirkhani, M Kashi Scientific Journal of Iran Blood Transfus Organ 3 (3), 265-271, 2006 | 11 | 2006 |
Seroepidemiologic evaluation of Rh system major antigens (D, C, E, c, e) and their phenotypes among the blood donors in Khorramabad, Iran J ABDI, ALIA KIANI THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON) 6 …, 2009 | 7 | 2009 |